Antitumor Immune Responses Derived from Transgenic Expression of CD40 Ligand in Myeloma Cells-Reference-Cited by-同舟云学术

Antitumor Immune Responses Derived from Transgenic Expression of CD40 Ligand in Myeloma Cells

Published:2002-02 Issue:1 Volume:17 Page:11-18
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Liu Yongqing¹,Qureshi Mabood²,Xiang Jim³

Affiliation:

1. Saskatoon Cancer Center, Department of Microbiology, University of Saskatchewan, Saskatoon, Saskatchewan S7N 0W0.

2. Saskatoon Cancer Center, Departments of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan S7N 0W0.

3. Saskatoon Cancer Center, Departments of Microbiology, University of Saskatchewan, Saskatoon, Saskatchewan S7N 0W0.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10849780252824028

Reference28 articles.

1. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

2. Mouse Myeloma Cell Line Secreting Bifunctional Fusion Protein RM4/IFN-τ Elicits Antitumor CD8 MHC Class I-Restricted T Cells That Are Cytolytic In Vitro and Tumoricidal In Vivo

3. Efficacy of tnf-α gene-transduced tumor cells in treatment of establishedin vivo tumor

4. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system;Frontiers of Medicine;2020-08-13

2. Enhanced Protective Immunity Derived from Dendritic Cells with Phagocytosis of CD40 Ligand Transgene-engineered Apoptotic Tumor Cells via Increased Dendritic Cell Maturation;Tumori Journal;2015-05-15

3. Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines;Cancer Immunology, Immunotherapy;2014-01-03

4. Immune Co-signaling to Treat Cancer;Cancer Immunotherapy;2012-09-19

5. Vaccinations With Dendritic Cells Primed With Apoptotic Tumor Cells Can Elicit Preventive Antitumor Immunity in a Poorly Immunogenic Animal Model of Squamous Cell Carcinoma;The Laryngoscope;2007-09